Hemophilia Treatment Drugs Market - Global Industry Analysis

Hemophilia Treatment Drugs Market by Product Type (Recombinant Coagulation Factor Concentrates, Plasma Derived Coagulation Factor Concentrates, Desmopressin, and Antifibrinolytic Agents), by Disease Type (Hemophilia A, Hemophilia B, and Others), and by Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and E-Commerce) - Global Industry Perspective, Comprehensive Analysis and Forecast, 2017 - 2024

Published Date: 04-Jul-2018 Category: Pharmaceutical Report Format : PDF Pages: 110 Report Code: ZMR-3187 Status : Published

Global hemophilia treatment drugs market expected to generate revenue of around USD 25.61 billion by the end of 2024, growing at a CAGR of around 5.7% between 2017 and 2024. Hemophilia is a genetic disorder in which the blood clotting factors are reduced; this hampers the function of blood clotting and leads to abnormal internal and external bleeding after any type of injuries.

Request Free Brochure of Hemophilia Treatment Drugs Market

Your personal details are safe and secured with us. Privacy Policy SSL site seal - click to verify

Office Address

Contact Us

Zion Market Research
Tel: +1 (844) 845-5245
USA/Canada Toll Free No.+1 (855) 465-4651

Asia Pacific Office

3rd Floor, Mrunal Paradise, Opp Maharaja Hotel, Pimple Gurav, Pune 411061, Maharashtra, India
Phone No 020-46277770

Contact #

US OFFICE NO +1 (844) 845-5245
US/CAN TOLL FREE +1 (855) 465-4651
Email: sales@zionmarketresearch.com

We Are On Social

Business Hours

Our support available to help you 24 hours a day, five days a week.

Monday - Friday: 9AM - 6PM

Saturday - Sunday: Closed